Tecentriq atezolizumab: Phase Ib data

Data from a cohort of 24 evaluable patients with metastatic triple-negative breast cancer (TNBC) in an open-label, U.S. Phase

Read the full 191 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE